Psychopharmacology research has amassed substantial evidence for similarities between synthetic cathinones and other commonly abused psychostimulants. Few studies have utilized drug discrimination methods to investigate synthetic cathinones, and the precise neurochemical substrates underlying their interoceptive effects have not been examined. The present study assessed the involvement of D 1 and D 2 dopaminergic receptors in the stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and mephedrone (MEPH) in rats trained to discriminate D-amphetamine. Eight male Sprague-Dawley rats were trained to discriminate 0.5 mg/kg D-amphetamine (AMPH) from saline. Dose-response curves were then generated with AMPH (0.0-1.0 mg/kg), MDPV (0.0-1.0 mg/kg), and MEPH (0.0-2.0 mg/kg). Subsequently, Sch 39166 (0.3 mg/kg) and haloperidol (0.5 mg/kg) were administered in combination with select doses of MDPV and MEPH. Both MDPV and MEPH produced full substitution for AMPH. Sch 39166 produced a downward shift in the MDPV and MEPH dose-response curves and haloperidol produced similar results with MDPV. These preliminary findings indicate that MDPV and MEPH produce interoceptive stimuli that are similar to those produced by AMPH and that D 1 and D 2 dopamine receptors contribute to these effects. Additional studies are warranted to investigate the contribution of other receptor mechanisms involved in the interoceptive stimuli produced by synthetic cathinones. Behavioural Pharmacology 28:586-589
Introduction
In the early-to-mid 2000s, synthetic cathinone derivatives were introduced as alternatives to illicit psychostimulants in the USA and the UK (Winstock and Ramsey, 2010; Goodnough and Zezima, 2011) . The popularity of synthetic cathinones soon gave rise to significant public health concerns, indicated by numerous incident reports from law enforcement and hospital emergency rooms. In 2011, the US Drug Enforcement Administration added synthetic cathinones to the schedule I list of controlled substances (Drug Enforcement Administration DEA, 2011) . Despite their illicit status, these substances are still abused recreationally (Ashrafioun et al., 2016) and new derivatives continue to be introduced to the illicit drug market.
Methylone, 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone [mephedrone (MEPH)] were among the first generation of synthetic cathinones (Valente et al., 2014) . As such, most of the extant preclinical literature has focused on these substances. A growing body of research supports the legal restriction of these substances, as their pharmacology and abuse liability are comparable to other abused psychostimulants (Baumann et al., 2012; Cameron et al., 2013) . However, only a few published studies have examined the interoceptive effects of MDPV or MEPH using animal models of drug discrimination (Fantegrossi et al., 2013; Gatch et al., 2013; Varner et al., 2013; Gannon et al., 2016) . To date, no published studies have examined the specific receptor mechanisms contributing to the interoceptive stimulus effects of these substances. The aim of the present study was to assess the involvement of D 1 and D 2 dopaminergic receptors in the stimulus effects of MDPV and MEPH in rats trained to discriminate D-amphetamine.
Methods

Subjects
Eight adult male Sprague-Dawley rats (350-450 g) were housed individually in polycarbonate cages with Teklad corncob bedding (#7097; Envigo, Madison, Wisconsin, USA). The animal facilities were maintained at 20 2°C and a humidity of 50 5% under a 12 : 12 light/dark cycle (lights on from 07:00 to 19:00 h). The animals were given free access to water in the home cages and commercial rodent diet (LabDiet 5001; PMI Nutrition Int. LLC, Brentwood, Missouri, USA) was restricted to maintain 85-90% of free-feeding weights. All procedures were reviewed and approved by the Western Michigan University Institutional Animal Care and Use Committee and were in accordance with the guidelines of the Guide for the Care and Use of Laboratory Animals (National Research Council of the National Academies, 2011) and EU Directive 2010/63/EU.
Apparatus
Training and testing were conducted in eight soundattenuated operant conditioning chambers (ENV-001; Med Associates Inc., St. Albans, Vermont, USA) and experiments were controlled using Med-PC software (version IV; Med Associates Inc.). The animals received 45 mg Dustless Precision Pellets (Product# F0021; BioServ Inc., Flemington, New Jersey, USA) as reinforcers during training sessions.
Procedures
Preliminary training, discrimination training, and stimulus generalization testing procedures were identical to those used in previous studies in our laboratory and described elsewhere (Harvey and Baker, 2016) . Rats were trained to reliably discriminate 0. Drugs D-Amphetamine-hemisulfate (Sigma-Aldrich Corp., St. Louis, Missouri, USA), Sch 39166 (Schering-Plough, Kenilworth, New Jersey, USA), 3,4-methylenedioxypyrovalerone-hydrochloride, and mephedrone-hydrochloride (National Institute on Drug Abuse, Bethesda, Maryland, USA) were each dissolved in 0.9% sodium chloride. Haloperidol (Sigma-Aldrich Corp.) was first dissolved in a few drops of 0.1 M HCl before being added to sterile water and then pH adjusted with 0.1 M NaOH. All drugs were administered by means of intraperitoneal injections at a constant volume of 1 ml/kg body weight. All doses were calculated based on the weights of solid compound.
Data analysis
Dose-response curves were graphed for each test compound alone and in combination with each antagonist, with the mean percentage of drug-appropriate lever responses ( SEM) as well as the mean SEM response rate (lever presses/s) plotted as a function of test dose. Substitution test results were included for any rat that emitted at least 10 responses on either lever during a test session. Response rate was included for all tests regardless of the number of responses made. For test compounds that displayed full substitution (>80% drug-appropriate responding), ED 50 values were calculated using straight-line regression of the linear portion of each dose-response curve. A one-way repeated-measures (RM) analysis of variance (ANOVA) was conducted on response rates obtained during test sessions with each compound. Graphical and statistical analyses were conducted using GraphPad Prism (version 6; GraphPad Software Inc., La Jolla, California, USA).
Results
Stimulus generalization
Dose-response curves generated from stimulus generalization tests with AMPH, MDPV, and MEPH, and stimulus antagonism tests with MDPV and MEPH in combination with Sch 39166 (0.3 mg/kg) or haloperidol (0.5 mg/kg) are displayed in Fig. 1 . AMPH produced a dose-dependent increase in AMPH-lever responding with full substitution at the 1.0 mg/kg dose. The ED 50 value for AMPH was calculated at 0.28 mg/kg [95% confidence interval (CI): 0.003-0.47 mg/kg]. A one-way RM ANOVA showed a statistically significant effect of AMPH dose on response rate (F 4, 28 = 2.86, P < 0.05). Dunnett's multiple comparison tests indicated that 1.0 mg/kg AMPH significantly reduced response rate compared with saline (P < 0.05).
MDPV produced a dose-dependent increase in AMPHappropriate responding and fully substituted at the 0.50 mg/kg dose. The ED 50 for MDPV was estimated at 0.15 mg/kg (95% CI: 0.04-0.25 mg/kg). A one-way RM ANOVA indicated a statistically significant overall effect of MDPV dose on response rate (F 5, 35 = 3.78, P < 0.01). Dunnett's multiple comparisons found that response rates were significantly decreased following 0.25 mg/kg (P < 0.05), 0.50 mg/kg (P < 0.05), and 1.0 mg/kg (P < 0.01) MDPV compared with response rates following saline injections.
MEPH yielded dose-dependent increases in AMPHlever responding and produced full substitution at 2.0 mg/kg. The ED 50 for MEPH was 1.15 mg/kg (95% CI: 0.83-1.60 mg/kg). A one-way RM ANOVA revealed a statistically significant effect of MEPH dose on response rate (F 4, 28 = 9.73, P < 0.001). Dunnett's multiple comparison tests indicated that 1.0 mg/kg (P < 0.05) and 2.0 mg/kg (P < 0.01) MEPH significantly lowered response rate compared with saline.
Stimulus antagonism
Sch 39166 (0.3 mg/kg) produced a marked downward shift in the dose-response curves for both MDPV and MEPH at all doses tested, with haloperidol (0.5 mg/kg) producing similar results with doses of MDPV. Specifically, doses of MDPV (0.5 mg/kg) and MEPH (2.0 mg/kg) that previously produced full substitution failed to do so when administered in combination with Sch 39166 or haloperidol.
Stimulus effects of MDPV and mephedrone Harvey et al. 587 One-way RM ANOVA tests did not find any significant effects on response rates following administration of either antagonist with MDPV or MEPH compared with rates following the antagonists alone. However, paired t-tests did find that Sch 39166 administered alone significantly reduced response rate compared with vehicle alone [t(7) = 4.19, P < 0.01], as did haloperidol [t(6) = 2.49, P < 0.05].
Discussion
The primary aim of this study was to evaluate the contribution of D 1 and D 2 dopamine receptors to the discriminative stimulus effects of MDPV and MEPH in rats trained to discriminate the closely related and wellcharacterized psychostimulant, AMPH. The current results that MDPV and MEPH produced full substitution for AMPH are consistent with previous reports that these substances share similar discriminative stimulus effects with cocaine and methamphetamine (Gatch et al., 2013; Varner et al., 2013; Gannon et al., 2016) .
Neurochemical studies indicate that MDPV exerts its effects primarily through the uptake blockade of the dopamine transporter, with only very weak effects on monoamine release. In contrast, MEPH is a nonselective releaser at the dopamine transporter, as well as the serotonin transporter and the norepinephrine transporter (Baumann et al., 2013; Eshleman et al., 2013) . The direct involvement of dopaminergic actions in MDPV's effects is supported by the present findings that MDPV substitution for AMPH was attenuated by both the D 1 receptor antagonist Sch 39166 and the D 2 antagonist haloperidol. Interestingly, Sch 39166 also attenuated MEPH substitution. Previous findings from our laboratory showed that MEPH fully substituted in rats trained to discriminate MDMA (a potent serotonin releaser) from saline (Harvey and Baker, 2016) . Considered together, these results may suggest that MEPH produces interoceptive stimulus effects through both dopaminergic (i.e. amphetamine-like) and serotonergic (i.e. MDMA-like) mechanisms. It should be noted, however, that Sch 39166 also significantly reduced response rates, indicating that it may have nonspecific global effects that interfered with the discrimination of the test drugs.
The current study did not assess Sch 39166 or haloperidol for antagonism of AMPH, precluding a direct comparison of their effects on MDPV or MEPH stimulus generalization to their effects on the training stimulus. However, previous reports indicate potent blockade of the AMPH discriminative cue by these antagonists (Exner et al., 1989; Callahan et al., 1991; West et al., 1995; Powell and Holtzman, 2000) . Considered together with previous findings, the current results strongly indicate that MDPV and MEPH stimulus generalization for AMPH can be attributed to their actions on dopamine receptors.
Conclusion
These results indicate that MDPV and MEPH produce interoceptive stimuli similar to those produced by the potent stimulant, AMPH. These stimulant-like effects appear to be at least in part mediated by both the D 1 and the D 2 dopamine receptors. However, additional antagonism tests are needed to determine whether these effects persist at antagonist doses that do not produce significant reductions in overall response rate. Further, given that MEPH has been found to influence both serotonergic and dopaminergic activities in the brain, future tests with 5-hydroxytryptamine antagonists are warranted in order to determine the extent to which each of these components contribute to its overall discriminative stimulus properties.
